SURGE THERAPEUTICS

surge-therapeutics-logo

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed. The company provides an injectable biodegradable hydrogel that allows for the prolonged, localized release of most cancer immunotherapy on the website of surgical tumor resection by focusing the dose at the right place and right time.

#SimilarOrganizations #People #Financial #Website #More

SURGE THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2016-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.surgetx.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
58 M USD

Technology used in webpage:
Euro GoDaddy


Similar Organizations

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

iroko-pharmaceuticals-logo

Iroko Pharmaceuticals

Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.

kytopen-logo

Kytopen

Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.

nference-logo

nference

nference is an Artificial Intelligence (AI)-powered venture creation engine

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโ€‘based treatments for cardiovascular disease.

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells


Current Advisors List

kouki-harasaki_image

Kouki Harasaki Board Member @ SURGE Therapeutics
Board_member

Current Employees Featured

michael-goldberg_image

Michael Goldberg
Michael Goldberg CEO and Founder @ SURGE Therapeutics
CEO and Founder
2018-10-01

Founder


michael-goldberg_image

Michael Goldberg

Investors List

camford-capital_image

Camford Capital

Camford Capital investment in Series B - SURGE Therapeutics

piedmont-capital_image

Piedmont Capital

Piedmont Capital investment in Series B - SURGE Therapeutics

green-d-ventures-a230_image

Green D Ventures

Green D Ventures investment in Series B - SURGE Therapeutics

intuitive-ventures_image

Intuitive Ventures

Intuitive Ventures investment in Series B - SURGE Therapeutics

alumni-ventures-group_image

Alumni Ventures

Alumni Ventures investment in Series B - SURGE Therapeutics

cancer-research-institute_image

Cancer Research Institute

Cancer Research Institute investment in Series B - SURGE Therapeutics

castor-ventures_image

Castor Ventures

Castor Ventures investment in Series B - SURGE Therapeutics

pitango-venture-capital_image

Pitango VC

Pitango VC investment in Series B - SURGE Therapeutics

khosla-ventures_image

Khosla Ventures

Khosla Ventures investment in Series B - SURGE Therapeutics

danhua-capital_image

DHVC

DHVC investment in Series B - SURGE Therapeutics

Official Site Inspections

http://www.surgetx.com

  • Host name: 253.103.167.72.host.secureserver.net
  • IP address: 72.167.103.253
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "SURGE Therapeutics"

Team โ€“ SURGE Therapeutics

Chuck Carignan CXO. Dr. Charles S. Carignan is the Executive Chairman of Cairdac and of โ€ฆSee details»

SURGE Therapeutics - Crunchbase Company Profile

Contact Email [email protected] SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is โ€ฆSee details»

Surge Therapeutics - Overview, News & Similar companies

Surge Therapeutics contact info: Phone number: (617) 909-8181 Website: www.surgetx.com โ€ฆSee details»

SURGE Therapeutics - LinkedIn

SURGE Therapeutics | 1,431 followers on LinkedIn. The intraoperative immunotherapy company | SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer ...See details»

Surge Therapeutics Inc - Drug pipelines, Patents, Clinical trials

Www.surgetx.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. โ€ฆSee details»

Surge Therapeutics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Surge โ€ฆSee details»

Contact Us โ€“ SURGE Therapeutics

123-456-7890. SURGE © 2024. All Rights Reserved. Contact us at info[at]surgetx.comSee details»

Surge Therapeutics - VentureRadar

Website: https://surgetx.com. Develops cancer therapies aiming to enhance patient survival by โ€ฆSee details»

SURGE Therapeutics Raises $32M Series B Financing to โ€ฆ

The SURGERxโ„ข platform is designed to improve the efficacy and safety of immunotherapy treatment, concentrating the effective dose where and when it may yield tremendous impact. SURGE is based in Cambridge, MA. For more โ€ฆSee details»

SURGE - Products, Competitors, Financials, Employees, โ€ฆ

Surgetx.com. Overview & Products; Financials; People; Founded Year 2016. Stage Series B | โ€ฆSee details»

SURGE Therapeutics Information - RocketReach

Surgetx.com; View Similar People. Related Companies Converge Consulting, LLC. 49 $769k โ€ฆSee details»

Surge Therapeutics - PitchBook

Surge Therapeutics General Information Description. Developer of a proprietary technology โ€ฆSee details»

Surge Therapeutics - Craft

Surge Therapeutics is a biotechnology company focused on developing solutions for cancer โ€ฆSee details»

SURGE Therapeutics Raises $32M Series B Financing to Advance ...

Jul 19, 2023 SURGE is based in Cambridge, MA. For more information, visit โ€ฆSee details»

Science โ€“ SURGE Therapeutics

Improving cancer immunotherapy through nanotechnology. The 2018 Nobel Prize in โ€ฆSee details»

SURGE Therapeutics Raises $32M Series B Financing to Advance ...

Jul 19, 2023 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- SURGE Therapeutics (SURGE), a โ€ฆSee details»

News โ€“ SURGE Therapeutics

Immunotherapy during surgery? Surge Therapeutics nabs $32M to expand clinical plans after โ€ฆSee details»

Cancer: How a novel gel could halt its return

Jun 11, 2021 Groundbreaking research has revealed a promising strategy to stop the โ€ฆSee details»

Gradual release of immunotherapy at site of tumor surgery โ€ฆ

Jun 1, 2021 A new study by Dana-Farber Cancer Institute scientists suggests it may be โ€ฆSee details»

linkstock.net © 2022. All rights reserved